Livagen
Research profile · How we handle evidence
Peptide that supports liver function and regeneration, helping to protect and restore liver health.
Evidence Score
Preclinical signal
Category
Therapeutic area
Standard Dose
Daily
Half-life
Plasma elimination
Route
Subcutaneous
Safety Tier
Limited data
Overview
Livagen is a liver-support peptide from the bioregulator peptide niche. It’s commonly discussed as a tissue-support / regeneration-signaling concept aimed at liver cells under stress. The publicly available evidence is mostly preclinical or indirect, and user reports vary, so it’s best read as educational context rather than a guaranteed liver “fix.” If you’re monitoring liver enzymes (for example ALT/AST), people typically discuss giving any intervention enough time to be reflected in labs, but the right approach depends on your situation and should be done with clinician guidance. Some stacks pair Livagen with BPC-157 or Thymosin Alpha-1 for broader organ-support framing.
Mechanism of Action
Livagen is a liver-support peptide from the bioregulator peptide niche. It’s commonly discussed as a tissue-support / regeneration-signaling concept aimed at liver cells under stress. The publicly available evidence is mostly preclinical or indirect, and user reports vary, so it’s best read as educational context rather than a guaranteed liver “fix.” If you’re monitoring liver enzymes (for example ALT/AST), people typically discuss giving any intervention enough time to be reflected in labs, but the right approach depends on your situation and should be done with clinician guidance. Some stacks pair Livagen with BPC-157 or Thymosin Alpha-1 for broader organ-support framing.
pH & Mixing
Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.
A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.
Benefits
- Liver support
- Hepatoprotection
- Regeneration support
- Detoxification support
Side Effects
- Reported as generally well-tolerated in limited user reports
- Human side-effect data is not well-established
Contraindications
- Pregnant or breastfeeding women
- Liver disease
Structure & Sequence
Verified structure
Livagen
Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.
- Amino Acid Sequence
- Lys-Glu-Asp-Ala (KEDA)
- Molecular Weight
- 461.5 Da
- Chemical Formula
- C18H31N5O9
- CAS Number
- N/A
- Reconstituted pH
- 4.2
Stack & Route Context
Stacks with
- Thymosin Alpha-1
- BPC-157
Administration
Subcutaneous
Research Status
Research peptide for liver health
Approval Status
Preclinical
Sports Legal
Permitted
References
- 1View source
PubChem: Livagen (search starting point for structure/properties)
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.